期刊文献+

葛根素对自发性高血压大鼠胸主动脉结构和功能的影响(英文) 被引量:8

Effect of puerarin on structure and function of thoracic aorta in spontaneously hypertensive rats
下载PDF
导出
摘要 目的探讨葛根素对自发性高血压大鼠(SHR)胸主动脉结构和功能的影响及其降压机制。方法12周龄SHR适应性喂养及血压测量训练1周后,ip给予葛根素25,50和100 mg.kg-1,给药6周。以第1次给药为第1周初,分别于给药前及给药后第2,4和6周测量血压。用硝酸还原酶法检测血清一氧化氮(NO)含量,放免法测量血浆内皮素1(ET-1)含量;HE染色观察胸主动脉形态学改变。制备胸主动脉环,采用累积加药法检测各组动脉环对苯肾上腺素(PE)10-9~10-5mol.L-1及乙酰胆碱(ACh)10-7~10-3mol.L-1引起的收缩或舒张反应。结果与对照组WKY大鼠相比,SHR模型组血压升高,ET-1增多,NO减少(P<0.01);血管肌层有大量脂质及纤维组织沉积,内皮边缘粗糙不平滑。与SHR模型组相比,葛根素25,50和100 mg.kg-1组血压分别降低了6.7±1.0,5.1±0.6和(2.2±0.3)kPa,差异显著(P<0.05);葛根素100 mg.kg-1组NO含量升高了1倍(P<0.01),ET-1含量降低了(36.3±4.2)%(P<0.05);血管肌层增生及脂质、纤维组织浸润明显好转,内皮也较平滑;降低PE对胸主动脉的收缩程度(P<0.05),增大ACh对胸主动脉的舒张程度(P<0.05)。结论葛根素对SHR具有良好的降压作用。其降压机制可能与其减弱SHR血管肾上腺素受体敏感性、保护血管内皮、增加血管内皮依赖性舒血管作用及纠正血液中血管舒缩因子失衡有关。 OBJECTIVE To observe the effect of puerarin on the relaxing and contracting factors in blood and on structure and function of thoracic artery rings in vitro in spontaneously hypertensive rats(SHRs) so as to explore its antihypertensive mechanisms.METHODS After 12-week-old male SHRs were adaptively fed and blood pressure was practically measured for one week,puerarin 25,50,and 100 mg·kg-1 was given intraperitoneally for six weeks.In addition,SHR and WKY control groups were set up.Each group contained 7 rats.The first administration was regarded as the start of the first week.Blood pressure was measured at baseline,2nd,4th and 6th week.Contents of endothelin-1(ET-1) in plasma and nitric oxide(NO) in serum were detected by radioimmunoassay and nitric acid reductase,respectively.Changes in morphology of the thoracic aorta were observed by HE staining.The response of the thoracic aorta to phenephrine(PE)10-9-10-5 mol·L-1 or acetylcholine(ACh) 10-7-10-3 mol·L-1 was measured with an additive concentration method.RESULTS Compared with WKY group,blood pressure increased in SHR model group;content of ET-1 increased and that of NO decreased(P0.01);fibrous tissue was proliferated within the vascular layer with large lipid and fibrous deposits,and the verge of endodermis was rough.Compared with SHR model group,puerarin 25,50,100 mg·kg-1 significantly lowered blood pressure by 6.7±1.0,5.1±0.6 and(2.2±0.3)kPa,respectively(P0.05).The level of NO doubled(P0.01) and that of ET-1 decreased by(36.3±4.2)%(P0.05) in puerain 100 mg·kg-1 group;smooth muscle proliferation and lipid and fibrous deposits in the thoracic aorta improved;contractile response to PE decreased(P0.05) and relaxation response to ACh increased(P0.05).CONCLUSION Puerarin has a substantial antihypertensive effect on SHRs,and its mechanism may be related to reducing sensitivity of the vessels to catecholamines,protecting vascular endothelium,increasing endothelium-dependent relaxation and improving the disequilibrium between vasodilating and vasoconstricting substances.
出处 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2012年第5期595-601,共7页 Chinese Journal of Pharmacology and Toxicology
基金 The project supported by Provinicial Natural Science Foundation of Anhui Province(070413124) the Fresh Start Foundation of Wannan Medical College(BK00010804)~~
关键词 葛根素 高血压 大鼠 近交SHR 一氧化氮 内皮素1 动脉环 puerarin hypertension rats inbred SHR nitric oxide endothelin-1 artery rings
  • 相关文献

参考文献16

  • 1Pierdomenico SD, Di Nicola M, Esposito AL, Di Mascio R, Ballone E, Lapenna D, et al. Prognostic value of different indices of blood pressure variability in hypertensive patients[J]. Am J Hypertens, 2009, 22(8):842-847.
  • 2Riccioni G. The effect of antihypertensive drugs on carotid intima media thickness: an up-to-date review[J]. Curr Med Chem, 2009, 16(8):988-996.
  • 3de las Heras N, Ruiz-Ortega M, Miana M, Rupérez M, Sanz-Rosa D, Aragoncillo P, et al. Interactions between aldosterone and connective tissue growth factor in vascular and renal damage in spontaneously hypertensive rats[J]. J Hypertens, 2007, 25(3):629-638.
  • 4Li J, Zhou Z, Jiang DJ, Li D, Tan B, Liu H, et al. Reduction of NO- and EDHF-mediated vasodilatation in hypertension: role of asymmetric dimethylarginine[J]. Clin Exp Hypertens, 2007, 29(7):489-501.
  • 5董侃,陶谦民,夏强,单绮娴,潘国标.葛根素的非内皮依赖性血管舒张作用机制[J].中国中药杂志,2004,29(10):981-984. 被引量:31
  • 6Yan LP, Zhuang YL, Chan SW, Chen SL, Shi GG. Analysis of the mechanisms underlying the endothelium-dependent antivasoconstriction of puerarin in rat aorta[J]. Naunyn Schmiedebergs Arch Pharmacol, 2009, 379(6):587-597.
  • 7Meng XH, Ni C, Zhu L, Shen YL, Wang LL, Chen YY. Puerarin protects against high glucose-induced acute vascular dysfunction: role of heme oxygenase-1 in rat thoracic aorta[J]. Vasc Pharmacol, 2009, 50(3-4):110-115.
  • 8Garg K, Yadav HN, Singh M, Sharma PL. Mechanism of cardioprotective effect of erythropoietin-induced preconditioning in rat heart[J]. Indian J Pharmacol, 2010, 42(4):219-223.
  • 9Bonini MG, Stadler K, Silva SO, Corbett J, Dore M, Petranka J, et al. Constitutive nitric oxide synthase activation is a significant route for nitroglycerin-mediated vasodilation[J]. Proc Natl Acad Sci USA, 2008, 105(25):8569-8574.
  • 10Kim HY, Choi JH, Kang YJ, Park SY, Choi HC, Kim HS. Reparixin, an inhibitor of CXCR1 and CXCR2 receptor activation, attenuates blood pressure and hypertension-related mediators expression in spontaneously hypertensive rats[J]. Biol Pharm Bull, 2011, 34(1):120-127.

二级参考文献13

  • 1Brunner H, Cockcroft JR, Deanfield J, et al. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension [ J ]. J Hypertens ,2005 ;23:233 - 246.
  • 2Niu LG, Zhang MS, Liu Y, et al. Vasorelaxant effect of taurine is diminished by tetraethylammonium in rat isolated arteries[J]. Eur J Pharmacol, 2008 ;580 : 169 - 174.
  • 3Rush JW, Ford RJ. Nitric oxide, oxidative stress and vascular endothelium in health and hypertension [ J ]. Clin Hemorheol Microcirc, 2007 ;37 : 185 - 192.
  • 4Johnson FK, Johnson RA, Peyton KJ, et al. Arginase inhibition restores artefiolar endothelial function in Dahl rats with salt - induced hypertension[ J]. Am J Physiol Regul Integr Comp Physiol, 2005; 288 : 1057 - 1062.
  • 5Levy AS, Chung JC, Kroetsch JT, et al. Nitric oxide and coronary vascular endothelium adaptations in hypertension [ J ].Vasc Health Risk Manag, 2009 ;5 : 1075 - 1087.
  • 6Sonoyama K, Greenstein A, Price A, et al. Vascular remodeling: implications for small artery function and target organ damage[ J]. Ther Adv Cardiovasc Dis, 2007 ;1:129 - 137.
  • 7Risler NR, Cruzado MC, Miatello RM. Vascular remodeling in experimental hypertension [ J ]. Sci World J, 2005 ;5:959 - 971.
  • 8Luksha L, Agewall S, Kublickiene IC Endothelium - derived hyperpolarizing factor in vascular physiology and cardiovascular disease [ J ]. Atherosclerosis, 2009 ;202:330 - 344.
  • 9Heeneman S, Sluimer JC, Daemen MJ. Angiotensin - converting enzyme and vascular remodeling [ J ]. Circ Res, 2007 ; 101:441 - 454.
  • 10Rembold,C M.Regulation of contraction and relaxation in arterial smooth muscle.Hypertension,1992,20(2):129.

共引文献41

同被引文献168

引证文献8

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部